<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2020-10-07" version="187">
<accession>Q07352</accession>
<accession>Q13851</accession>
<name>TISB_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="30">mRNA decay activator protein ZFP36L1</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="26 27">Butyrate response factor 1</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="28">EGF-response factor 1</fullName>
<shortName evidence="28">ERF-1</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="5">TPA-induced sequence 11b</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="31">Zinc finger protein 36, C3H1 type-like 1</fullName>
<shortName evidence="31">ZFP36-like 1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="31">ZFP36L1</name>
<name type="synonym" evidence="29">BERG36</name>
<name type="synonym" evidence="26 27">BRF1</name>
<name type="synonym" evidence="28">ERF1</name>
<name type="synonym">RNF162B</name>
<name type="synonym" evidence="5">TIS11B</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Nucleic Acids Res." volume="21" first="3580" last="3580">
<title>Coding sequence of ERF-1, the human homologue of Tis11b/cMG1, members of the Tis11 family of early response genes.</title>
<authorList>
<person name="Barnard R.C."/>
<person name="Pascall J.C."/>
<person name="Brown K.D."/>
<person name="McKay I.A."/>
<person name="Williams N.S."/>
<person name="Bustin S.A."/>
</authorList>
<dbReference type="PubMed" id="8346037"/>
<dbReference type="DOI" id="10.1093/nar/21.15.3580"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="DNA Cell Biol." volume="13" first="449" last="459">
<title>Cloning and characterization of ERF-1, a human member of the Tis11 family of early-response genes.</title>
<authorList>
<person name="Bustin S.A."/>
<person name="Nie X.F."/>
<person name="Barnard R.C."/>
<person name="Kumar V."/>
<person name="Pascall J.C."/>
<person name="Brown K.D."/>
<person name="Leigh I.M."/>
<person name="Williams N.S."/>
<person name="McKay L.A."/>
</authorList>
<dbReference type="PubMed" id="8024689"/>
<dbReference type="DOI" id="10.1089/dna.1994.13.449"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Eur. J. Immunol." volume="26" first="2356" last="2363">
<title>Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36.</title>
<authorList>
<person name="Ning Z.Q."/>
<person name="Norton J.D."/>
<person name="Li J."/>
<person name="Murphy J.J."/>
</authorList>
<dbReference type="PubMed" id="8898945"/>
<dbReference type="DOI" id="10.1002/eji.1830261013"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1998" name="Br. J. Biomed. Sci." volume="55" first="184" last="191">
<title>Differential effects of sodium butyrate on the transcription of the human TIS11 family of early-response genes in colorectal cancer cells.</title>
<authorList>
<person name="Maclean K.N."/>
<person name="McKay I.A."/>
<person name="Bustin S.A."/>
</authorList>
<dbReference type="PubMed" id="10367403"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="4709" last="4718">
<title>Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover.</title>
<authorList>
<person name="Stoecklin G."/>
<person name="Colombi M."/>
<person name="Raineri I."/>
<person name="Leuenberger S."/>
<person name="Mallaun M."/>
<person name="Schmidlin M."/>
<person name="Gross B."/>
<person name="Lu M."/>
<person name="Kitamura T."/>
<person name="Moroni C."/>
</authorList>
<dbReference type="PubMed" id="12198173"/>
<dbReference type="DOI" id="10.1093/emboj/cdf444"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF CYS-120 AND CYS-158</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="324" first="218" last="223">
<title>Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells.</title>
<authorList>
<person name="Reppe S."/>
<person name="Olstad O.K."/>
<person name="Rian E."/>
<person name="Gautvik V.T."/>
<person name="Gautvik K.M."/>
<person name="Jemtland R."/>
</authorList>
<dbReference type="PubMed" id="15465005"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.09.030"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="4760" last="4769">
<title>The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B.</title>
<authorList>
<person name="Schmidlin M."/>
<person name="Lu M."/>
<person name="Leuenberger S.A."/>
<person name="Stoecklin G."/>
<person name="Mallaun M."/>
<person name="Gross B."/>
<person name="Gherzi R."/>
<person name="Hess D."/>
<person name="Hemmings B.A."/>
<person name="Moroni C."/>
</authorList>
<dbReference type="PubMed" id="15538381"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600477"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>INTERACTION WITH YWHAB</scope>
<scope>PHOSPHORYLATION AT SER-90 AND SER-92</scope>
<scope>MUTAGENESIS OF SER-90 AND SER-92</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="8673" last="8680">
<title>Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b.</title>
<authorList>
<person name="Ciais D."/>
<person name="Cherradi N."/>
<person name="Bailly S."/>
<person name="Grenier E."/>
<person name="Berra E."/>
<person name="Pouyssegur J."/>
<person name="Lamarre J."/>
<person name="Feige J.J."/>
</authorList>
<dbReference type="PubMed" id="15467755"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207939"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Genes Dev." volume="19" first="351" last="361">
<title>Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1.</title>
<authorList>
<person name="Lykke-Andersen J."/>
<person name="Wagner E."/>
</authorList>
<dbReference type="PubMed" id="15687258"/>
<dbReference type="DOI" id="10.1101/gad.1282305"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A MRNA DECAY ACTIVATION COMPLEX</scope>
<scope>INTERACTION WITH CNOT6; DCP1A; DCP2; EXOSC2 AND XRN1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="169" first="871" last="884">
<title>Stress granules and processing bodies are dynamically linked sites of mRNP remodeling.</title>
<authorList>
<person name="Kedersha N."/>
<person name="Stoecklin G."/>
<person name="Ayodele M."/>
<person name="Yacono P."/>
<person name="Lykke-Andersen J."/>
<person name="Fritzler M.J."/>
<person name="Scheuner D."/>
<person name="Kaufman R.J."/>
<person name="Golan D.E."/>
<person name="Anderson P."/>
</authorList>
<dbReference type="PubMed" id="15967811"/>
<dbReference type="DOI" id="10.1083/jcb.200502088"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="9497" last="9507">
<title>BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites.</title>
<authorList>
<person name="Benjamin D."/>
<person name="Schmidlin M."/>
<person name="Min L."/>
<person name="Gross B."/>
<person name="Moroni C."/>
</authorList>
<dbReference type="PubMed" id="17030608"/>
<dbReference type="DOI" id="10.1128/mcb.01099-06"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>INTERACTION WITH YWHAB</scope>
<scope>PHOSPHORYLATION AT SER-203</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-92 AND SER-203</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="Genes Dev." volume="21" first="719" last="735">
<title>TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements.</title>
<authorList>
<person name="Franks T.M."/>
<person name="Lykke-Andersen J."/>
</authorList>
<dbReference type="PubMed" id="17369404"/>
<dbReference type="DOI" id="10.1101/gad.1494707"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="RNA" volume="14" first="950" last="959">
<title>The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2.</title>
<authorList>
<person name="Maitra S."/>
<person name="Chou C.F."/>
<person name="Luber C.A."/>
<person name="Lee K.Y."/>
<person name="Mann M."/>
<person name="Chen C.Y."/>
</authorList>
<dbReference type="PubMed" id="18326031"/>
<dbReference type="DOI" id="10.1261/rna.983708"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CNOT6; DCP2; EXOSC2 AND YWHAB</scope>
<scope>PHOSPHORYLATION AT SER-54; SER-92 AND SER-203</scope>
<scope>MUTAGENESIS OF SER-54; SER-92 AND SER-203</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Mol. Endocrinol." volume="23" first="497" last="509">
<title>cAMP-dependent posttranscriptional regulation of steroidogenic acute regulatory (STAR) protein by the zinc finger protein ZFP36L1/TIS11b.</title>
<authorList>
<person name="Duan H."/>
<person name="Cherradi N."/>
<person name="Feige J.J."/>
<person name="Jefcoate C."/>
</authorList>
<dbReference type="PubMed" id="19179481"/>
<dbReference type="DOI" id="10.1210/me.2008-0296"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Growth Factors" volume="28" first="178" last="190">
<title>ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production.</title>
<authorList>
<person name="Hacker C."/>
<person name="Valchanova R."/>
<person name="Adams S."/>
<person name="Munz B."/>
</authorList>
<dbReference type="PubMed" id="20166898"/>
<dbReference type="DOI" id="10.3109/08977190903578660"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="3340" last="3351">
<title>ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway.</title>
<authorList>
<person name="Vignudelli T."/>
<person name="Selmi T."/>
<person name="Martello A."/>
<person name="Parenti S."/>
<person name="Grande A."/>
<person name="Gemelli C."/>
<person name="Zanocco-Marani T."/>
<person name="Ferrari S."/>
</authorList>
<dbReference type="PubMed" id="20702587"/>
<dbReference type="DOI" id="10.1091/mbc.e10-01-0040"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Mol. Biol. Cell" volume="22" first="3625" last="3633">
<title>A novel function of Tis11b/BRF1 as a regulator of Dll4 mRNA 3'-end processing.</title>
<authorList>
<person name="Desroches-Castan A."/>
<person name="Cherradi N."/>
<person name="Feige J.J."/>
<person name="Ciais D."/>
</authorList>
<dbReference type="PubMed" id="21832157"/>
<dbReference type="DOI" id="10.1091/mbc.e11-02-0149"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Am. Soc. Nephrol." volume="25" first="2213" last="2221">
<title>Hypertonicity compromises renal mineralocorticoid receptor signaling through Tis11b-mediated post-transcriptional control.</title>
<authorList>
<person name="Viengchareun S."/>
<person name="Lema I."/>
<person name="Lamribet K."/>
<person name="Keo V."/>
<person name="Blanchard A."/>
<person name="Cherradi N."/>
<person name="Lombes M."/>
</authorList>
<dbReference type="PubMed" id="24700863"/>
<dbReference type="DOI" id="10.1681/asn.2013091023"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>MUTAGENESIS OF CYS-120 AND CYS-158</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54 AND SER-318</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="10037" last="10049">
<title>ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK-RSK pathway.</title>
<authorList>
<person name="Adachi S."/>
<person name="Homoto M."/>
<person name="Tanaka R."/>
<person name="Hioki Y."/>
<person name="Murakami H."/>
<person name="Suga H."/>
<person name="Matsumoto M."/>
<person name="Nakayama K.I."/>
<person name="Hatta T."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
</authorList>
<dbReference type="PubMed" id="25106868"/>
<dbReference type="DOI" id="10.1093/nar/gku652"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>INTERACTION WITH CNOT1 AND CNOT7</scope>
<scope>PHOSPHORYLATION AT SER-334</scope>
<scope>MUTAGENESIS OF SER-334 AND SER-336</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E102625" last="E102625">
<title>Post-transcriptional regulation of BCL2 mRNA by the RNA-binding protein ZFP36L1 in malignant B cells.</title>
<authorList>
<person name="Zekavati A."/>
<person name="Nasir A."/>
<person name="Alcaraz A."/>
<person name="Aldrovandi M."/>
<person name="Marsh P."/>
<person name="Norton J.D."/>
<person name="Murphy J.J."/>
</authorList>
<dbReference type="PubMed" id="25014217"/>
<dbReference type="DOI" id="10.1371/journal.pone.0102625"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2015" name="Sci. Rep." volume="5" first="16229" last="16229">
<title>ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6.</title>
<authorList>
<person name="Chen M.T."/>
<person name="Dong L."/>
<person name="Zhang X.H."/>
<person name="Yin X.L."/>
<person name="Ning H.M."/>
<person name="Shen C."/>
<person name="Su R."/>
<person name="Li F."/>
<person name="Song L."/>
<person name="Ma Y.N."/>
<person name="Wang F."/>
<person name="Zhao H.L."/>
<person name="Yu J."/>
<person name="Zhang J.W."/>
</authorList>
<dbReference type="PubMed" id="26542173"/>
<dbReference type="DOI" id="10.1038/srep16229"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2016" name="Eur. J. Cell Biol." volume="95" first="277" last="284">
<title>Functional analysis of ZFP36 proteins in keratinocytes.</title>
<authorList>
<person name="Prenzler F."/>
<person name="Fragasso A."/>
<person name="Schmitt A."/>
<person name="Munz B."/>
</authorList>
<dbReference type="PubMed" id="27182009"/>
<dbReference type="DOI" id="10.1016/j.ejcb.2016.04.007"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="J. Mol. Biol." volume="346" first="1367" last="1379">
<title>Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide.</title>
<authorList>
<person name="Hulsmeyer M."/>
<person name="Welfle K."/>
<person name="Pohlmann T."/>
<person name="Misselwitz R."/>
<person name="Alexiev U."/>
<person name="Welfle H."/>
<person name="Saenger W."/>
<person name="Uchanska-Ziegler B."/>
<person name="Ziegler A."/>
</authorList>
<dbReference type="PubMed" id="15713487"/>
<dbReference type="DOI" id="10.1016/j.jmb.2004.12.047"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 325-333 IN COMPLEX WITH MAJOR HISTOCOMPATIBILITY COMPLEX HLA</scope>
</reference>
<comment type="function">
<text evidence="4 5 8 10 11 12 13 14 15 16 17 19 20 21 22 23 24 25">Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis (PubMed:12198173, PubMed:15538381, PubMed:15467755, PubMed:17030608, PubMed:19179481, PubMed:20702587, PubMed:24700863, PubMed:25106868, PubMed:25014217, PubMed:26542173). Acts as a 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery (PubMed:15687258). Functions by recruiting the CCR4-NOT deadenylase complex and components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs, and hence promotes ARE-mediated mRNA deadenylation and decay processes (PubMed:15687258, PubMed:18326031, PubMed:25106868). Induces also the degradation of ARE-containing mRNAs even in absence of poly(A) tail (By similarity). Binds to 3'-UTR ARE of numerous mRNAs (PubMed:12198173, PubMed:15538381, PubMed:15467755, PubMed:17030608, PubMed:19179481, PubMed:20702587, PubMed:24700863, PubMed:25106868, PubMed:25014217, PubMed:26542173). Positively regulates early adipogenesis by promoting ARE-mediated mRNA decay of immediate early genes (IEGs) (By similarity). Promotes ARE-mediated mRNA decay of mineralocorticoid receptor NR3C2 mRNA in response to hypertonic stress (PubMed:24700863). Negatively regulates hematopoietic/erythroid cell differentiation by promoting ARE-mediated mRNA decay of the transcription factor STAT5B mRNA (PubMed:20702587). Positively regulates monocyte/macrophage cell differentiation by promoting ARE-mediated mRNA decay of the cyclin-dependent kinase CDK6 mRNA (PubMed:26542173). Promotes degradation of ARE-containing pluripotency-associated mRNAs in embryonic stem cells (ESCs), such as NANOG, through a fibroblast growth factor (FGF)-induced MAPK-dependent signaling pathway, and hence attenuates ESC self-renewal and positively regulates mesendoderm differentiation (By similarity). May play a role in mediating pro-apoptotic effects in malignant B-cells by promoting ARE-mediated mRNA decay of BCL2 mRNA (PubMed:25014217). In association with ZFP36L2 maintains quiescence on developing B lymphocytes by promoting ARE-mediated decay of several mRNAs encoding cell cycle regulators that help B cells progress through the cell cycle, and hence ensuring accurate variable-diversity-joining (VDJ) recombination and functional immune cell formation (By similarity). Together with ZFP36L2 is also necessary for thymocyte development and prevention of T-cell acute lymphoblastic leukemia (T-ALL) transformation by promoting ARE-mediated mRNA decay of the oncogenic transcription factor NOTCH1 mRNA (By similarity). Participates in the delivery of target ARE-mRNAs to processing bodies (PBs) (PubMed:17369404). In addition to its cytosolic mRNA-decay function, plays a role in the regulation of nuclear mRNA 3'-end processing; modulates mRNA 3'-end maturation efficiency of the DLL4 mRNA through binding with an ARE embedded in a weak noncanonical polyadenylation (poly(A)) signal in endothelial cells (PubMed:21832157). Also involved in the regulation of stress granule (SG) and P-body (PB) formation and fusion (PubMed:15967811). Plays a role in vasculogenesis and endocardial development (By similarity). Plays a role in the regulation of keratinocyte proliferation, differentiation and apoptosis (PubMed:27182009). Plays a role in myoblast cell differentiation (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="5 8 10 11 12 13 14 15 16 17 19 20 21 22 23 24 25">Associates with the cytoplasmic CCR4-NOT deadenylase and RNA exosome complexes to trigger ARE-containing mRNA deadenylation and decay processes (PubMed:15687258, PubMed:18326031, PubMed:25106868). Interacts with CNOT1 (PubMed:25106868). Interacts (via N-terminus) with CNOT6 (PubMed:15687258, PubMed:18326031). Interacts with CNOT7; this interaction is inhibited in response to phorbol 12-myristate 13-acetate (PMA) treatment in a p38 MAPK-dependent manner (PubMed:25106868). Interacts with DCP1A (PubMed:15687258). Interacts (via N-terminus) with DCP2 (PubMed:15687258, PubMed:18326031). Interacts (via N-terminus) with EXOSC2 (PubMed:15687258, PubMed:18326031). Interacts with XRN1 (PubMed:15687258). Interacts (via phosphorylated form) with YWHAB; this interaction occurs in a protein kinase AKT1-dependent manner (PubMed:15538381, PubMed:17030608, PubMed:18326031). Interacts (via phosphorylated form) with YWHAZ; this interaction occurs in a p38 MAPK- and AKT-signaling pathways (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-721823">
<id>Q07352</id>
</interactant>
<interactant intactId="EBI-73946">
<id>Q16539</id>
<label>MAPK14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Cytoplasmic granule</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13 15">Cytoplasm</location>
<location evidence="13 15">P-body</location>
</subcellularLocation>
<text evidence="5 13 15">Shuttles between the nucleus and the cytoplasm in a XPO1/CRM1-dependent manner (By similarity). Component of cytoplasmic stress granules (PubMed:15967811). Localizes in processing bodies (PBs) (PubMed:17369404).</text>
</comment>
<comment type="tissue specificity">
<text evidence="9 25">Expressed mainly in the basal epidermal layer, weakly in the suprabasal epidermal layers (PubMed:27182009). Expressed in epidermal keratinocytes (at protein level) (PubMed:27182009). Expressed in osteoblasts (PubMed:15465005).</text>
</comment>
<comment type="induction">
<text evidence="7 9 17 18 20 24 25">Down-regulated under hypoxic conditions in endothelial cells (at protein level) (PubMed:21832157). Up-regulated by growth factor (TGF-beta), cytokines, tumor necrosis factor (TNF-alpha) and epidermal growth factor (EGF) in keratinocytes (PubMed:20166898). Up-regulated also by glucocorticoid dexamethasone in keratinocytes (PubMed:20166898). Up-regulated in keratinocytes in response to wounding in a p38 MAPK-dependent manner (PubMed:20166898, PubMed:27182009). Up-regulated by the parathyroid hormone (PTH) in osteoblast-like cells in a cAMP/PKA-dependent manner (PubMed:15465005, PubMed:19179481). Up-regulated in response to adrenocorticotropic hormone (ACTH) (PubMed:19179481). Up-regulated during monocyte/macrophage differentiation in response to phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) (PubMed:26542173). Down-regulated by butyrate in colorectal cancer cells (PubMed:10367403).</text>
</comment>
<comment type="PTM">
<text evidence="5 11 14 16 17 23">Phosphorylated (PubMed:19179481). Phosphorylated by RPS6KA1 at Ser-334 upon phorbol 12-myristate 13-acetate (PMA) treatment; this phosphorylation results in dissociation of the CCR4-NOT deadenylase complex and induces p38 MAPK-mediated stabilization of the low-density lipoprotein receptor LDLR mRNA (PubMed:25106868). Phosphorylated by protein kinase AKT1 at Ser-92 and Ser-203 in response to insulin; these phosphorylations stabilize ZFP36L1, increase the association with 14-3-3 proteins and mediate ARE-containing mRNA stabilization (PubMed:15538381, PubMed:17030608). AKT1-mediated phosphorylation at Ser-92 does not impair ARE-containing RNA-binding (PubMed:15538381). Phosphorylated at Ser-54, Ser-92 and Ser-203 by MAPKAPK2; these phosphorylations increase the association with 14-3-3 proteins and mediate ARE-containing mRNA stabilization in a protein kinase AKT1-independent manner (PubMed:18326031). MAPKAPK2-mediated phosphorylations at Ser-54, Ser-92 and Ser-203 do not impair ARE-containing RNA-binding (PubMed:18326031). Phosphorylations increase the association with 14-3-3 proteins and mediate ARE-containing mRNA stabilization during early adipogenesis in a p38 MAPK- and AKT-dependent manner (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="14">Ubiquitinated. Ubiquitination leads to proteasomal degradation, a process inhibited by phosphorylations at Ser-90, Ser-92 and Ser-203 (PubMed:17030608).</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ZFP36L1ID42866ch14q22.html"/>
</comment>
<dbReference type="EMBL" id="X79066">
<property type="protein sequence ID" value="CAA55670.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X79067">
<property type="protein sequence ID" value="CAA55670.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X99404">
<property type="protein sequence ID" value="CAA67781.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019468">
<property type="protein sequence ID" value="AAV38275.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC018340">
<property type="protein sequence ID" value="AAH18340.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9791.1"/>
<dbReference type="PIR" id="S34854">
<property type="entry name" value="S34854"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001231627.1">
<property type="nucleotide sequence ID" value="NM_001244698.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001231630.1">
<property type="nucleotide sequence ID" value="NM_001244701.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004917.2">
<property type="nucleotide sequence ID" value="NM_004926.3"/>
</dbReference>
<dbReference type="PDB" id="1W0V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="C=325-333"/>
</dbReference>
<dbReference type="PDB" id="1W0W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="C=325-333"/>
</dbReference>
<dbReference type="PDBsum" id="1W0V"/>
<dbReference type="PDBsum" id="1W0W"/>
<dbReference type="SMR" id="Q07352"/>
<dbReference type="BioGRID" id="107144">
<property type="interactions" value="17"/>
</dbReference>
<dbReference type="CORUM" id="Q07352"/>
<dbReference type="IntAct" id="Q07352">
<property type="interactions" value="11"/>
</dbReference>
<dbReference type="MINT" id="Q07352"/>
<dbReference type="STRING" id="9606.ENSP00000388402"/>
<dbReference type="iPTMnet" id="Q07352"/>
<dbReference type="PhosphoSitePlus" id="Q07352"/>
<dbReference type="BioMuta" id="ZFP36L1"/>
<dbReference type="DMDM" id="1351254"/>
<dbReference type="EPD" id="Q07352"/>
<dbReference type="jPOST" id="Q07352"/>
<dbReference type="MassIVE" id="Q07352"/>
<dbReference type="MaxQB" id="Q07352"/>
<dbReference type="PaxDb" id="Q07352"/>
<dbReference type="PeptideAtlas" id="Q07352"/>
<dbReference type="PRIDE" id="Q07352"/>
<dbReference type="ProteomicsDB" id="58515"/>
<dbReference type="Antibodypedia" id="37">
<property type="antibodies" value="350 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="677"/>
<dbReference type="Ensembl" id="ENST00000336440">
<property type="protein sequence ID" value="ENSP00000337386"/>
<property type="gene ID" value="ENSG00000185650"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000439696">
<property type="protein sequence ID" value="ENSP00000388402"/>
<property type="gene ID" value="ENSG00000185650"/>
</dbReference>
<dbReference type="GeneID" id="677"/>
<dbReference type="KEGG" id="hsa:677"/>
<dbReference type="UCSC" id="uc001xkh.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="677"/>
<dbReference type="DisGeNET" id="677"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000185650.9"/>
<dbReference type="GeneCards" id="ZFP36L1"/>
<dbReference type="HGNC" id="HGNC:1107">
<property type="gene designation" value="ZFP36L1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000185650">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="601064">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q07352"/>
<dbReference type="OpenTargets" id="ENSG00000185650"/>
<dbReference type="PharmGKB" id="PA35027"/>
<dbReference type="eggNOG" id="KOG1677">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155076"/>
<dbReference type="HOGENOM" id="CLU_033040_1_0_1"/>
<dbReference type="InParanoid" id="Q07352"/>
<dbReference type="KO" id="K18753"/>
<dbReference type="OMA" id="PMSESPN"/>
<dbReference type="OrthoDB" id="1541140at2759"/>
<dbReference type="PhylomeDB" id="Q07352"/>
<dbReference type="TreeFam" id="TF315463"/>
<dbReference type="PathwayCommons" id="Q07352"/>
<dbReference type="Reactome" id="R-HSA-450385">
<property type="pathway name" value="Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA"/>
</dbReference>
<dbReference type="SIGNOR" id="Q07352"/>
<dbReference type="BioGRID-ORCS" id="677">
<property type="hits" value="114 hits in 896 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ZFP36L1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q07352"/>
<dbReference type="GeneWiki" id="ZFP36L1"/>
<dbReference type="GenomeRNAi" id="677"/>
<dbReference type="Pharos" id="Q07352">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q07352"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 14"/>
</dbReference>
<dbReference type="RNAct" id="Q07352">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000185650">
<property type="expression patterns" value="Expressed in oviduct epithelium and 244 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q07352">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q07352">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000932">
<property type="term" value="C:P-body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990904">
<property type="term" value="C:ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071889">
<property type="term" value="F:14-3-3 protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000255"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0035925">
<property type="term" value="F:mRNA 3'-UTR AU-rich region binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003729">
<property type="term" value="F:mRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061158">
<property type="term" value="P:3'-UTR-mediated mRNA destabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071320">
<property type="term" value="P:cellular response to cAMP"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044344">
<property type="term" value="P:cellular response to fibroblast growth factor stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071385">
<property type="term" value="P:cellular response to glucocorticoid stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071375">
<property type="term" value="P:cellular response to peptide hormone stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097403">
<property type="term" value="P:cellular response to raffinose"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071472">
<property type="term" value="P:cellular response to salt stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071560">
<property type="term" value="P:cellular response to transforming growth factor beta stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060710">
<property type="term" value="P:chorio-allantoic fusion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070371">
<property type="term" value="P:ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048382">
<property type="term" value="P:mesendoderm development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006397">
<property type="term" value="P:mRNA processing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051028">
<property type="term" value="P:mRNA transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035264">
<property type="term" value="P:multicellular organism growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045647">
<property type="term" value="P:negative regulation of erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901991">
<property type="term" value="P:negative regulation of mitotic cell cycle phase transition"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021915">
<property type="term" value="P:neural tube development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000288">
<property type="term" value="P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031086">
<property type="term" value="P:nuclear-transcribed mRNA catabolic process, deadenylation-independent decay"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038066">
<property type="term" value="P:p38MAPK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045600">
<property type="term" value="P:positive regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904582">
<property type="term" value="P:positive regulation of intracellular mRNA localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045657">
<property type="term" value="P:positive regulation of monocyte differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900153">
<property type="term" value="P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003342">
<property type="term" value="P:proepicardium development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043491">
<property type="term" value="P:protein kinase B signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045577">
<property type="term" value="P:regulation of B cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902172">
<property type="term" value="P:regulation of keratinocyte apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045616">
<property type="term" value="P:regulation of keratinocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010837">
<property type="term" value="P:regulation of keratinocyte proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031440">
<property type="term" value="P:regulation of mRNA 3'-end processing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043488">
<property type="term" value="P:regulation of mRNA stability"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045661">
<property type="term" value="P:regulation of myoblast differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072091">
<property type="term" value="P:regulation of stem cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009611">
<property type="term" value="P:response to wounding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060712">
<property type="term" value="P:spongiotrophoblast layer development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033077">
<property type="term" value="P:T cell differentiation in thymus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001570">
<property type="term" value="P:vasculogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR007635">
<property type="entry name" value="Tis11B_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR000571">
<property type="entry name" value="Znf_CCCH"/>
</dbReference>
<dbReference type="InterPro" id="IPR036855">
<property type="entry name" value="Znf_CCCH_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF04553">
<property type="entry name" value="Tis11B_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00642">
<property type="entry name" value="zf-CCCH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00356">
<property type="entry name" value="ZnF_C3H1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF90229">
<property type="entry name" value="SSF90229"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50103">
<property type="entry name" value="ZF_C3H1"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0509">mRNA transport</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0687">Ribonucleoprotein</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="mRNA decay activator protein ZFP36L1" id="PRO_0000089167">
<location>
<begin position="1"/>
<end position="338"/>
</location>
</feature>
<feature type="zinc finger region" description="C3H1-type 1" evidence="6">
<location>
<begin position="114"/>
<end position="142"/>
</location>
</feature>
<feature type="zinc finger region" description="C3H1-type 2" evidence="6">
<location>
<begin position="152"/>
<end position="180"/>
</location>
</feature>
<feature type="region of interest" description="Necessary and sufficient for the association with mRNA decay enzymes and mRNA decay activation" evidence="12">
<location>
<begin position="1"/>
<end position="111"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for mRNA decay activation" evidence="12">
<location>
<begin position="185"/>
<end position="338"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="307"/>
<end position="316"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPKAPK2" evidence="1 2 3 16">
<location>
<position position="54"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1" evidence="11">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1 and MAPKAPK2" evidence="11 16">
<location>
<position position="92"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1 and MAPKAPK2" evidence="14 16">
<location>
<position position="203"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="318"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RPS6KA1" evidence="23">
<location>
<position position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits MAPKAPK2-mediated ARE-containing mRNA stabilization; when associated with A-92 and A-203." evidence="16">
<original>S</original>
<variation>A</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with 14-3-3 proteins and AKT1-mediated ARE-containing mRNA stabilization, but does not affect ARE binding; when associated with A-92." evidence="11">
<original>S</original>
<variation>A</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits MAPKAPK2-mediated ARE-containing mRNA stabilization; when associated with A-54 and A-203. Inhibits interaction with 14-3-3 proteins and AKT1-mediated ARE-containing mRNA stabilization; when associated with A-203. Inhibits interaction with 14-3-3 proteins and AKT1-mediated ARE-containing mRNA stabilization, but does not affect ARE binding; when associated with A-90." evidence="11 14 16">
<original>S</original>
<variation>A</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding to ARE-containing mRNAs and ARE-mediated mRNA decay. Inhibits binding to ARE-containing mRNAs and ARE-mediated mRNA decay; when associated with R-158." evidence="8 21">
<original>C</original>
<variation>R</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding to ARE-containing mRNAs and ARE-mediated mRNA decay. Inhibits binding to ARE-containing mRNAs and ARE-mediated mRNA decay; when associated with R-120." evidence="8 21">
<original>C</original>
<variation>R</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with 14-3-3 proteins and AKT1-mediated ARE-containing mRNA stabilization; when associated with A-92. Inhibits MAPKAPK2-mediated ARE-containing mRNA stabilization; when associated with A-54 and A-92." evidence="14 16">
<original>S</original>
<variation>A</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits p38 MAPK-mediated LDLR mRNA stabilization, but does not inhibit interaction with CNOT1 and CNOT7; when associated with A-336." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits p38 MAPK-mediated LDLR mRNA stabilization, but does not inhibit interaction with CNOT1 and CNOT7; when associated with A-334." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAA67781." ref="3" evidence="30">
<original>H</original>
<variation>R</variation>
<location>
<position position="63"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P17431"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P23950"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00723"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10367403"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12198173"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15465005"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15467755"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15538381"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15687258"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15967811"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17030608"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17369404"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18326031"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19179481"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20166898"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20702587"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21832157"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24700863"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25014217"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25106868"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26542173"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27182009"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10367403"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12198173"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8346037"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8898945"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<evidence key="31" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:1107"/>
</source>
</evidence>
<sequence length="338" mass="36314" checksum="98236CD40C4531D2" modified="1996-02-01" version="1">MTTTLVSATIFDLSEVLCKGNKMLNYSAPSAGGCLLDRKAVGTPAGGGFPRRHSVTLPSSKFHQNQLLSSLKGEPAPALSSRDSRFRDRSFSEGGERLLPTQKQPGGGQVNSSRYKTELCRPFEENGACKYGDKCQFAHGIHELRSLTRHPKYKTELCRTFHTIGFCPYGPRCHFIHNAEERRALAGARDLSADRPRLQHSFSFAGFPSAAATAAATGLLDSPTSITPPPILSADDLLGSPTLPDGTNNPFAFSSQELASLFAPSMGLPGGGSPTTFLFRPMSESPHMFDSPPSPQDSLSDQEGYLSSSSSSHSGSDSPTLDNSRRLPIFSRLSISDD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

